Case-based debate: is there evidence for local treatment in oligometastatic prostate cancer?
Reducing diagnostic delay for better cancer outcomes
Newer oncogene addictions in NSCLC
Straightforward study design: SPARTAN trial of apalutamide for nmCRPC
Live long and PROSPER: enzalutamide for nmCRPC